Horizon Pharma to buy Hyperion Therapeutics

Horizon Pharma (Nasdaq: HZNP) will pay a premium of approximately $1.1 billion in cash to buy Hyperion Therapeutics Inc. (Nasdaq: HPTX). Shares of Horizon soared $3.28 to $25.09 while Hyperion stock climbed $3.36 to $46.10.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.